Results 1 to 10 of about 367 (132)
Randomized clinical trial comparing removal followed by topical imiquimod versus removal followed by topical methylprednisolone in the treatment of keloids [PDF]
Acta Cirúrgica BrasileiraPurpose: Keloids are unaesthetic benign dermatosis characterized by a disorganized proliferation of collagen. Treatment of keloids constitutes a therapeutic challenge.
Alexandre Spiandorello Ricciardi +5 more
doaj +2 more sources
Педиатрическая фармакология, 2014 The article is dedicated to the issues of external therapy of atopic dermatitis in children. Atopic dermatitis is a chronic allergic inflammatory skin disease; in most cases, it is the first manifestation of atopic march. Timely and adequate pathogenetic
Yu. G. Levina +4 more
doaj +3 more sources
Development and validation of a method to quantify methylprednisolone aceponate in cream by micellar liquid chromatography. [PDF]
Anal Bioanal ChemAbstract Adventan cream is a widely prescribed topical medication used to treat various skin disorders. We have developed a method based on micellar liquid chromatography to quantify its active component, methylprednisolone aceponate, which is an essential step for effective quality control.
Romero-Salicio E +5 more
europepmc +4 more sources
Педиатрическая фармакология, 2018 The article describes the main characteristics of local glucocorticosteroids (GCS) which are the «gold standard» for external therapy of atopic dermatitis allowing to achieve control over the disease quickly and effectively. Methylprednisolone aceponate
Yuliya G. Levina +4 more
doaj +3 more sources
Clinical experience with methylprednisolone aceponate (MPA) in eczema
Journal of Dermatological Treatment, 1992 Effectiveness and side-effects of the new topical halogenfree corticosteroid methylprednisolone aceponate (MPA) (0.1% in commercial o/w or w/o emulsions) were tested in six multicentre controlled double-blind studies, using betamethasone valerate (BMV) as control (0.1% in o/w emulsion); a total of 1723 patients with various kinds of eczema were ...
exaly +2 more sources
Methylprednisolone aceponate (MPA)* — a new therapeutic for eczema: A pharmacological overview
Journal of Dermatological Treatment, 1992 Advantan* is a new potent corticoid preparation that has been specially developed for the local treatment of eczematous dermatoses. The active ingredient of Advantan is methylprednisolone aceponate (MPA), a nonhalogenated corticoid diester. Advantan has been developed in three different formulations (cream, ointment, fatty ointment).
U Tauber
exaly +2 more sources
Journal of Dermatological Treatment, 1992 Methylprednisolone aceponate (MPA, Advantan*) is a new corticosteroid diester developed for the topical treatment of steroid-responsive skin diseases. It is readily hydrolyzed in the skin resulting in its activation, and on absorption into the blood, the metabolites are rapidly inactivated by conjugation with glucuronic acid thus minimizing systemic ...
exaly +2 more sources
Лечащий Врач, 2021 The results of clinical monitoring of the effectiveness and safety of therapy in adult patients with atopic dermatitis using various dosage forms of methylprednisolone aceponate are presented.
N. V. Kungurov +4 more
doaj +1 more source
Experience in the treatment of dermatitis in children. Clinical examples
Медицинский совет, 2021 Modern external therapy of dermatoses is aimed at controlling the subjective symptoms, the dynamics of inflammatory manifestations, the achievement and duration of remission. The step-by-step approach to the treatment of dermatoses in children and adults
Natalia M. Sharova, Svetlana V. Kukalo
doaj +1 more source
Granulomatous perioral dermatitis [PDF]
Vestnik Dermatologii i Venerologii, 2023 Parents of patient S., born in 2018 applied with complaints of rashes on the skin of her daughter's face, accompanied by itching for a year. Topically used cream methylprednisolone aceponate and methylene blue.
Nadezhda V. Krasnova +3 more
doaj +1 more source